A comparative analysis of the epidemiology of influenza and respiratory syncytial virus in Russia, 2013/14 to 2018/19.
Journal
Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
9
2
2022
pubmed:
10
2
2022
medline:
11
2
2022
Statut:
epublish
Résumé
Influenza and respiratory syncytial virus (RSV) are among the leading causes of lower respiratory tract infections worldwide. We conducted a comparative analysis of the age distribution and spatiotemporal epidemiology of influenza and RSV in Russia using sentinel surveillance data from 2013-14 to 2018-19 in six cities located in the western, central, and eastern regions of the country. We calculated the positivity rate for influenza and RSV (by month, season, and overall) in each city, separately for patients seen at the primary and secondary care level (out-patients medical centres housing GP practices and infectious diseases hospitals, respectively). We compared the age distribution of patients infected with the different influenza virus (sub)types and RSV. A total of 17 551 respiratory specimens were included: the overall positivity rate was 13.5% for influenza and 4.4% for RSV. The A(H1N1)pdm09, A(H3N2) and B virus (sub)types caused 31.3%, 44.0% and, respectively, 24.7% of all influenza cases. The median age was older among influenza (15 years) than among RSV patients (3 years); differences across influenza virus (sub)types were seen only at the primary care level, with influenza A(H3N2) patients being significantly older than A(H1N1)pdm09 or B influenza patients. The timing of influenza epidemics was similar across cities, with the peak typically occurring in February or March. In contrast, the typical peak timing of RSV epidemics varied largely across cities, and the virus was often detected also in spring and summer months (unlike influenza). Influenza and RSV epidemiology differed in many regards in Russia, especially in the timing of epidemics and the age distribution of infected subjects. Health policies aimed at containing the burden of diseases of viral respiratory infections in Russia should take these findings into account.
Sections du résumé
BACKGROUND
BACKGROUND
Influenza and respiratory syncytial virus (RSV) are among the leading causes of lower respiratory tract infections worldwide. We conducted a comparative analysis of the age distribution and spatiotemporal epidemiology of influenza and RSV in Russia using sentinel surveillance data from 2013-14 to 2018-19 in six cities located in the western, central, and eastern regions of the country.
METHODS
METHODS
We calculated the positivity rate for influenza and RSV (by month, season, and overall) in each city, separately for patients seen at the primary and secondary care level (out-patients medical centres housing GP practices and infectious diseases hospitals, respectively). We compared the age distribution of patients infected with the different influenza virus (sub)types and RSV.
RESULTS
RESULTS
A total of 17 551 respiratory specimens were included: the overall positivity rate was 13.5% for influenza and 4.4% for RSV. The A(H1N1)pdm09, A(H3N2) and B virus (sub)types caused 31.3%, 44.0% and, respectively, 24.7% of all influenza cases. The median age was older among influenza (15 years) than among RSV patients (3 years); differences across influenza virus (sub)types were seen only at the primary care level, with influenza A(H3N2) patients being significantly older than A(H1N1)pdm09 or B influenza patients. The timing of influenza epidemics was similar across cities, with the peak typically occurring in February or March. In contrast, the typical peak timing of RSV epidemics varied largely across cities, and the virus was often detected also in spring and summer months (unlike influenza).
CONCLUSIONS
CONCLUSIONS
Influenza and RSV epidemiology differed in many regards in Russia, especially in the timing of epidemics and the age distribution of infected subjects. Health policies aimed at containing the burden of diseases of viral respiratory infections in Russia should take these findings into account.
Identifiants
pubmed: 35136600
doi: 10.7189/jogh.12.04009
pii: jogh-12-04009
pmc: PMC8818296
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
04009Informations de copyright
Copyright © 2022 by the Journal of Global Health. All rights reserved.
Déclaration de conflit d'intérêts
Competing interests: The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author), and declare no conflicts of interest.
Références
Euro Surveill. 2018 Feb;23(5):
pubmed: 29409569
PLoS One. 2019 Jul 29;14(7):e0220401
pubmed: 31356626
J Glob Health. 2020 Jun;10(1):010426
pubmed: 32566164
J Infect Public Health. 2019 May - Jun;12(3):357-363
pubmed: 30573330
J Clin Virol. 2011 Nov;52(3):215-21
pubmed: 21880543
MMWR Recomm Rep. 2019 Aug 23;68(3):1-21
pubmed: 31441906
CMAJ. 2021 Apr 12;193(15):E523
pubmed: 33846202
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
Influenza Other Respir Viruses. 2020 Nov;14(6):647-657
pubmed: 31670892
N Engl J Med. 2005 Apr 28;352(17):1749-59
pubmed: 15858184
Vestn Ross Akad Med Nauk. 2014;(7-8):54-66, 68
pubmed: 25563005
Gerontologist. 2016 Oct;56(5):795-9
pubmed: 26884065
Am J Epidemiol. 2007 Jun 15;165(12):1434-42
pubmed: 17369609
Euro Surveill. 2016 Apr 21;21(16):
pubmed: 27124420
Sci Rep. 2020 Jul 21;10(1):12106
pubmed: 32694533
Vaccine. 2020 Sep 29;38(42):6645-6655
pubmed: 32873403
BMC Infect Dis. 2018 Jun 8;18(1):269
pubmed: 29884140
Clin Infect Dis. 2021 Aug 16;73(4):726-729
pubmed: 33462610
Open Forum Infect Dis. 2020 Nov 12;7(12):ofaa546
pubmed: 33335940
PLoS One. 2019 Sep 12;14(9):e0222381
pubmed: 31513690
PLoS One. 2015 May 04;10(5):e0124122
pubmed: 25938466
PLoS Med. 2013 Nov;10(11):e1001552
pubmed: 24348203
Am J Infect Dis. 2013;9(3):77-93
pubmed: 26561480